RESEARCH

Major areas of investigative interest focus on the molecular biology and genetics underlying multisystem inflammatory rheumatic and autoimmune diseases, especially systemic lupus erythematosus, scleroderma, Sjogren's syndrome, polymyositis, rheumatoid arthritis and the spondyloarthropathies. State-of-the-art molecular genetic technology and analyses are being used to map susceptibility genes to these diseases and to identify biomarkers of disease activity and prognosis as well as to identify molecular pathways which can be targeted therapeutically.

Examples of our research include (click on study icon see bibliography):

NIH- Family Studies of Micro Satellite Gene Markers in Patients with Ankylosing Spondylitis
John D. Reveille, M.D., PI


 

LUMINA
NIH R01: Outcome of SLE in Minorities - Nature vs Nurture
John D. Reveille, M.D., PI

 

LASR 21st Century
Lupus, Arthritis, Scleroderma Research into the 21st century
Frank C. Arnett, M.D., PI
Serological and Immunogenetics Database for Research in Scleroderma and Other Autoimmune Connective Tissue Diseases

NIAMS SCOR
Specialized Center of Research in Scleroderma (1997 - 2006)
Frank C. Arnett, M.D., Director

SCOT
Scleroderma Cyclophosphamide or Transplant
(2005-2012)
Maureen D. Mayes, M.D., MPH, PI

In the fall of 2006, the Division of Rheumatology was awarded several major grants from the National Institutes of Health (NIH), Department of Defense (DoD) and the American College of Rheumatology (ACR).

TITLE
AGENCY
INVESTIGATOR
AMOUNT
The Austro-Anglo-American Spondylitis Consortium
NIH-NIAMS
John D. Reveille, MD
$5 MILLION
Center of Research Translation in Scleroderma
NIH-NIAMS
Frank C. Arnett, MD
$7.5 MILLION
Center for Clinical and Translational Sciences
NIH-NCRR
Frank C. Arnett, MD
$36 MILLION
Candidate Gene Polymorphisms in Scleroderma: Defining Genetic Susceptibility Factors
DoD
Maureen D. Mayes, MD MPH
$625,000
The Integrative Studies of Genetic and Environmental Factors in Scleroderma
DoD
Xiadong Zhou, MD
$928,125
Microarray analysis of peripheral blood cells in systemic sclerosis
ACR REF
Shervin Assassi, MD
$170,000

 


Internal Medicine General   Medical School   Health Science Center   
Contact  Author, PJL    Date of Last Edit

 

 
 
 
Scleroderma: Cyclophosphamide Or Transplantation